Invention Grant
US07955812B2 Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
有权
通过检测交联和淀粉样寡聚物的抗体来诊断阿尔茨海默氏病的方法
- Patent Title: Methods of diagnosing alzheimer's disease by detecting antibodies to cross-linked β-amyloid oligomers
- Patent Title (中): 通过检测交联和淀粉样寡聚物的抗体来诊断阿尔茨海默氏病的方法
-
Application No.: US11632784Application Date: 2005-07-19
-
Publication No.: US07955812B2Publication Date: 2011-06-07
- Inventor: Robert Moir , Rudolph Tanzi
- Applicant: Robert Moir , Rudolph Tanzi
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/US2005/025567 WO 20050719
- International Announcement: WO2006/014638 WO 20060209
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/543 ; G01N33/566 ; G01N33/96
Abstract:
The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease.
Public/Granted literature
- US20080267952A1 Antibodies to Cross-Linked Beta-Amyloid Protein Oligomers Public/Granted day:2008-10-30
Information query
IPC分类:
